RESULTS	Proportions of HibMenCY-TT recipients with rSBA 1:8 were 95.6 % ( MenC ) , 98.6 % ( MenY ) postdose-2 , 99 % for MenC/Y postdose 3 and 4 ; hSBA 1:4 were 95.5 % ( MenC ) , 89.8 % ( MenY ) postdose 2 , > 97 % for MenC/Y postdose 3 and 4 .\